1. Home
  2. MDGL vs BZ Comparison

MDGL vs BZ Comparison

Compare MDGL & BZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

N/A

Current Price

$435.78

Market Cap

10.0B

Sector

Health Care

ML Signal

N/A

BZ

KANZHUN LIMITED American Depository Shares

N/A

Current Price

$16.19

Market Cap

9.7B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
MDGL
BZ
Founded
2011
2013
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
10.0B
9.7B
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
MDGL
BZ
Price
$435.78
$16.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
3
Target Price
$637.92
$26.00
AVG Volume (30 Days)
351.2K
3.1M
Earning Date
05-19-2026
01-01-0001
Dividend Yield
N/A
1.04%
EPS Growth
41.32
N/A
EPS
N/A
N/A
Revenue
$180,133,000.00
N/A
Revenue This Year
$54.74
$15.60
Revenue Next Year
$45.72
$13.18
P/E Ratio
N/A
$22.61
Revenue Growth
N/A
N/A
52 Week Low
$265.00
$13.29
52 Week High
$615.00
$25.26

Technical Indicators

Market Signals
Indicator
MDGL
BZ
Relative Strength Index (RSI) 35.15 28.45
Support Level $410.78 $15.57
Resistance Level $452.22 $18.76
Average True Range (ATR) 19.68 0.60
MACD -0.95 -0.07
Stochastic Oscillator 11.02 8.79

Price Performance

Historical Comparison
MDGL
BZ

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About BZ KANZHUN LIMITED American Depository Shares

Kanzhun's Boss Zhipin job platform connects job seekers and employers. Boss Zhipin is China's largest online recruitment platform based on monthly active users, or MAU, and was established in 2014. Kanzhun earns revenue by providing services to enterprise customers primarily through its mobile app, which promotes engagement between recruiters and workers and operates on a recommendation basis powered by artificial intelligence. The platform specializes in transportation, logistics, construction, and service-based industries. About 85% of the companies looking to hire are small and medium-size enterprises. Its main competitors are 58.com, 51job, and Zhilian Zhaopin. Tencent has a 9.2% stake in Kanzhun.

Share on Social Networks: